RETRACTED ARTICLE: Exploring the Role of CLU in the Pathogenesis of Alzheimer’s Disease
- 21 August 2020
- journal article
- retracted article
- Published by Springer Nature in Neurotoxicity Research
- Vol. 39 (6) , 2108-2119
Abstract
Alzheimer’s disease (AD) is a chronic and devastating neurodegenerative disorder that is affecting elderly people at an increasing rate. Clusterin (CLU), an extracellular chaperone, is an ubiquitously expressed protein that can be identified in various body fluids and tissues. Expression of CLU can lead to various processes including suppression of complement system, lipid transport, chaperone function, and also controlling neuronal cell death and cell survival mechanisms. Studies have confirmed that the level of CLU expression is increased in AD. Furthermore, CLU also decreased the toxicity and aggregation of amyloid beta (Aβ). However when the Aβ level was far greater than CLU, then the amyloid generation was increased. CLU was also found to incorporate in the amyloid aggregates, which were more harmful as compared with the Aβ42 aggregates alone. Growing evidence indicates that CLU plays roles in AD pathogenesis via various processes, including aggregation and clearance of Aβ, neuroinflammation, lipid metabolism, Wnt signaling, copper homeostasis, and regulation of neuronal cell cycle and apoptosis. In this article, we represent the critical interaction of CLU and AD based on recent advances. Furthermore, we have also focused on the Aβ-dependent and Aβ-independent mechanisms by which CLU plays a role in AD pathogenesis.Keywords
This publication has 112 references indexed in Scilit:
- Clusterin (Apolipoprotein J), a Molecular Chaperone That Facilitates Degradation of the Copper-ATPases ATP7A and ATP7BJournal of Biological Chemistry, 2011
- Review Article: Genetics of Alzheimer DiseaseJournal of Geriatric Psychiatry and Neurology, 2010
- Association of Plasma Clusterin Concentration With Severity, Pathology, and Progression in Alzheimer DiseaseArchives of General Psychiatry, 2010
- Identification of Clusterin Domain Involved in NF-κB Pathway RegulationJournal of Biological Chemistry, 2010
- Extracellular chaperones modulate the effects of Alzheimer’s patient cerebrospinal fluid on Aβ1-42 toxicity and uptakeCell Stress and Chaperones, 2010
- NSAIDs prevent, but do not reverse, neuronal cell cycle reentry in a mouse model of Alzheimer diseaseJournal of Clinical Investigation, 2009
- Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapyNature Reviews Neuroscience, 2009
- Genetics of Alzheimer's Disease: A Centennial ReviewNeurologic Clinics, 2007
- Transport Pathways for Clearance of Human Alzheimer's Amyloid β-Peptide and Apolipoproteins E and J in the Mouse Central Nervous SystemJournal of Cerebral Blood Flow & Metabolism, 2007
- Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene databaseNature Genetics, 2007